Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-21, Stock:NVS, The news for the past five days is as follows:
2020-12-14: NEWS1: Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patients with COVID-19.
2020-12-15: NEWS1: Novartis' (NVS) COVID-19 Study Fails to Meet Primary Endpoint.NEWS2: 20 Biggest Healthcare Companies By Revenue.NEWS3: Novartis reports positive topline results from second Phase III trial of Beovu® in patients with diabetic macular edema.
2020-12-16: NEWS1: Novartis' (NVS) Entresto Gets FDA Panel Nod for Expanded Use.NEWS2: The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal.NEWS3: Novartis announces positive FDA Advisory Committee recommendation for use of Entresto® to treat patients with HFpEF.
2020-12-17: NEWS1: A new coalition takes on social justice in medicine.NEWS2: Novartis (NVS) to Acquire Neuroscience Company for Up to $770M.
2020-12-18: NEWS1: U.S. FDA declines approval of Novartis' cholesterol-lowering drug.NEWS2: Novartis receives complete response letter from U.S. FDA for inclisiran.NEWS3: Pharma Stock Roundup: FDA Emergency Nod to PFE/BNTX COVID-19 Vaccine, AZN to Buy ALXN.

Answer: Decrease